A detailed history of Sg Americas Securities, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Sg Americas Securities, LLC holds 41,145 shares of ADPT stock, worth $296,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,145
Previous 21,667 89.9%
Holding current value
$296,244
Previous $78,000 170.51%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$3.37 - $5.12 $65,640 - $99,727
19,478 Added 89.9%
41,145 $211,000
Q2 2024

Jul 12, 2024

BUY
$2.34 - $3.96 $50,700 - $85,801
21,667 New
21,667 $78,000
Q4 2023

Jan 12, 2024

BUY
$3.46 - $5.33 $41,004 - $63,165
11,851 Added 20.18%
70,571 $346,000
Q3 2023

Oct 13, 2023

BUY
$5.07 - $8.44 $94,596 - $157,473
18,658 Added 46.57%
58,720 $320,000
Q2 2023

Jul 10, 2023

SELL
$6.19 - $8.78 $227,742 - $323,033
-36,792 Reduced 47.87%
40,062 $269,000
Q1 2023

Apr 28, 2023

BUY
$7.8 - $10.11 $373,557 - $484,188
47,892 Added 165.36%
76,854 $679,000
Q4 2022

Feb 02, 2023

BUY
$6.26 - $9.34 $33,422 - $49,866
5,339 Added 22.6%
28,962 $221,000
Q3 2022

Oct 31, 2022

SELL
$6.5 - $12.67 $175,857 - $342,786
-27,055 Reduced 53.39%
23,623 $168,000
Q2 2022

Jul 29, 2022

BUY
$6.4 - $14.73 $162,809 - $374,716
25,439 Added 100.79%
50,678 $410,000
Q1 2022

Apr 29, 2022

BUY
$10.12 - $28.9 $13,793 - $39,390
1,363 Added 5.71%
25,239 $350,000
Q4 2021

Feb 07, 2022

BUY
$25.17 - $36.85 $333,804 - $488,704
13,262 Added 124.95%
23,876 $670,000
Q3 2021

Nov 01, 2021

BUY
$30.02 - $39.87 $89,129 - $118,374
2,969 Added 38.84%
10,614 $361,000
Q2 2021

Aug 12, 2021

SELL
$32.22 - $44.59 $601,096 - $831,871
-18,656 Reduced 70.93%
7,645 $312,000
Q1 2021

May 13, 2021

BUY
$37.26 - $67.74 $904,784 - $1.64 Million
24,283 Added 1203.32%
26,301 $1.06 Million
Q4 2020

Feb 04, 2021

SELL
$45.01 - $65.47 $403,469 - $586,873
-8,964 Reduced 81.62%
2,018 $119,000
Q3 2020

Nov 09, 2020

BUY
$35.79 - $48.81 $393,045 - $536,031
10,982 New
10,982 $534,000
Q1 2020

Apr 30, 2020

SELL
$16.96 - $34.16 $110,579 - $222,723
-6,520 Closed
0 $0
Q4 2019

Jan 28, 2020

BUY
$24.56 - $32.8 $160,131 - $213,855
6,520 New
6,520 $195,000
Q3 2019

Nov 04, 2019

SELL
$30.31 - $53.51 $454,650 - $802,650
-15,000 Closed
0 $0
Q2 2019

Jul 29, 2019

BUY
$40.3 - $48.3 $604,500 - $724,500
15,000 New
15,000 $724,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.03B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.